NDC 0713-0850

Griseofulvin

Griseofulvin

Griseofulvin is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Griseofulvin.

Product ID0713-0850_ec12736b-25fb-dea8-e053-2995a90a2d02
NDC0713-0850
Product TypeHuman Prescription Drug
Proprietary NameGriseofulvin
Generic NameGriseofulvin
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2022-11-01
Marketing CategoryANDA /
Application NumberANDA065438
Labeler NameCosette Pharmaceuticals, Inc.
Substance NameGRISEOFULVIN
Active Ingredient Strength125 mg/5mL
Pharm ClassesDecreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0713-0850-04

118 mL in 1 BOTTLE, PLASTIC (0713-0850-04)
Marketing Start Date2022-11-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Griseofulvin" or generic name "Griseofulvin"

NDCBrand NameGeneric Name
0472-0013GriseofulvinGriseofulvin
0713-0850GriseofulvinGriseofulvin
0781-5514GriseofulvinGriseofulvin
0781-5515GriseofulvinGriseofulvin
42794-012GriseofulvinGriseofulvin
42794-013GriseofulvinGriseofulvin
42794-014GriseofulvinGriseofulvin
62135-968GriseofulvinGriseofulvin (microsize)
64980-184GriseofulvinGriseofulvin
64980-185GriseofulvinGriseofulvin
64980-186GriseofulvinGriseofulvin
68682-519GriseofulvinGriseofulvin
68682-520GriseofulvinGriseofulvin
0884-0763Gris-PEGgriseofulvin
0884-0773Gris-PEGgriseofulvin
53808-0261Gris-PEGGRISEOFULVIN
62135-496Griseofulvin MICROSIZEgriseofulvin
62135-494Ultramicrosize GriseofulvinGriseofulvin
62135-495Ultramicrosize GriseofulvinGriseofulvin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.